- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 305/06 - Hydrogenosulfates
Patent holdings for IPC class C07C 305/06
Total number of patents in this class: 47
10-year publication summary
4
|
3
|
4
|
5
|
1
|
3
|
3
|
4
|
4
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
BASF SE | 20933 |
5 |
Translate bio, Inc. | 415 |
3 |
The Procter & Gamble Company | 22017 |
2 |
Allergan, Inc. | 2349 |
2 |
Bayer Cropscience AG | 2035 |
2 |
Lawrence Livermore National Security, LLC | 1937 |
2 |
Arkema France | 4110 |
2 |
Harcros Chemicals Inc. | 32 |
2 |
Ingevity South Carolina, LLC | 244 |
2 |
Ultimate EOR Services, LLC | 10 |
2 |
F. Hoffmann-La Roche AG | 7925 |
1 |
Hoffmann-La Roche Inc. | 3418 |
1 |
Halliburton Energy Services, Inc. | 20891 |
1 |
Merck Patent GmbH | 5831 |
1 |
Evonik Degussa GmbH | 1531 |
1 |
ExxonMobil Chemical Patents Inc. | 3980 |
1 |
Rohm and Haas Company | 2906 |
1 |
Dow Global Technologies LLC | 10363 |
1 |
Board of Regents, The University of Texas System | 5793 |
1 |
Korea Institute of Science and Technology | 2115 |
1 |
Other owners | 13 |